1. Home
  2. IOVA vs ATS Comparison

IOVA vs ATS Comparison

Compare IOVA & ATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • ATS
  • Stock Information
  • Founded
  • IOVA 2007
  • ATS 1978
  • Country
  • IOVA United States
  • ATS Canada
  • Employees
  • IOVA N/A
  • ATS N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • ATS
  • Sector
  • IOVA Health Care
  • ATS
  • Exchange
  • IOVA Nasdaq
  • ATS Nasdaq
  • Market Cap
  • IOVA 2.6B
  • ATS 3.0B
  • IPO Year
  • IOVA N/A
  • ATS 2023
  • Fundamental
  • Price
  • IOVA $7.72
  • ATS $30.95
  • Analyst Decision
  • IOVA Strong Buy
  • ATS Sell
  • Analyst Count
  • IOVA 9
  • ATS 2
  • Target Price
  • IOVA $23.33
  • ATS $30.50
  • AVG Volume (30 Days)
  • IOVA 5.4M
  • ATS 113.0K
  • Earning Date
  • IOVA 11-07-2024
  • ATS 01-01-0001
  • Dividend Yield
  • IOVA N/A
  • ATS N/A
  • EPS Growth
  • IOVA N/A
  • ATS N/A
  • EPS
  • IOVA N/A
  • ATS 0.97
  • Revenue
  • IOVA $90,858,000.00
  • ATS $2,112,471,468.00
  • Revenue This Year
  • IOVA $13,758.71
  • ATS N/A
  • Revenue Next Year
  • IOVA $171.64
  • ATS $9.43
  • P/E Ratio
  • IOVA N/A
  • ATS $31.86
  • Revenue Growth
  • IOVA 12751.20
  • ATS N/A
  • 52 Week Low
  • IOVA $6.70
  • ATS $24.82
  • 52 Week High
  • IOVA $18.33
  • ATS $44.70
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 34.10
  • ATS 50.19
  • Support Level
  • IOVA $7.64
  • ATS $30.63
  • Resistance Level
  • IOVA $8.14
  • ATS $31.67
  • Average True Range (ATR)
  • IOVA 0.36
  • ATS 0.79
  • MACD
  • IOVA -0.07
  • ATS -0.13
  • Stochastic Oscillator
  • IOVA 4.26
  • ATS 12.80

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About ATS ATS Corporation

ATS Corp is a Canada-based company that provides automation systems. The company designs and builds customized automated manufacturing and testing systems for customers, and provides pre- and post-automation services. The company's products comprise conveyor systems, automated electrified monorails, tray handlers, laser systems, and other hardware and software products. The company also provides pre-automation solutions, including strategic direction and planning services, as well as aftermarket support. The company's clients come from the life sciences, food and beverage transportation, consumer products and electronics, and energy sectors. The company generates the majority of its sales from the North American and European markets.

Share on Social Networks: